fluo-3 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harata, N; Kinukawa, J; Shimura, M; Tamai, M | 1 |
| Buckler, KJ; Feuvray, D; Lagadic-Gossmann, D; Le Prigent, K | 1 |
2 other study(ies) available for fluo-3 and Alloxan Diabetes
| Article | Year |
|---|---|
Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes.
Topics: Aniline Compounds; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gliclazide; Glyburide; Hypoglycemic Agents; Ionomycin; Ionophores; Ischemia; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Retina; Streptozocin; Xanthenes | 2005 |
Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats.
Topics: Aniline Compounds; Animals; Calcium; Cell Separation; Diabetes Mellitus, Experimental; Fluorescent Dyes; Heart Ventricles; Indoles; Intracellular Membranes; Male; Myocardium; Rats; Rats, Wistar; Reference Values; Sarcoplasmic Reticulum; Xanthenes | 1996 |